About this trial
PACU-HPI study evaluates the use of a hemodynamic monitor in the post-anesthetic recovery room on patients undergoing colorectal, hepatobiliary, and vascular surgery, to determine the feasibility of recruiting this surgical population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient ≥45 years old
Will undergo open colorectal, hepatobiliary, or vascular surgery;
Is expected to have an arterial cannula inserted intraoperatively;
Has an anticipated stay in PACU for at least 2 hours;
Disqualifiers
Planned admission to ICU;
Refusal to participate;
Previously enrolled in the study
Trial population
Surgical patients with cardiovascular disease risk factors undergoing colorectal, hepatobiliary, or vascular surgery.
Trial design
Cohort
Prospective
Treatments tested in this trial
Device: HemoSphere monitor and Acumen IQ sensor.
DevicePatients will be placed on this monitor for the duration of study in the PACU. Followed by 30-day phone call to record cardiovascular complications.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of intraoperative hypotension
Describe the incidence of hypotension defined as MAP \<65 intraoperatively.
Incidence of postoperative hypotension
Describe the incidence of postoperative hypotension defined as MAP \<65 in the PACU
Hemodynamic changes with treatment of hypotension
Described the changes in cardiac index with each medical treatment of a hypotensive episode.
Secondary outcomes
Sensitivity and Specificity of HPI
Sensitivity and Specificity of HPI compared to a hypotensive events in the postoperative setting
Cardiovascular outcomes
Number of patients with Mortality, MI, MINS, acute pulmonary edema, stroke, pulmonary embolism, deep vein thrombosis
Sponsors and contacts
Click on the lead sponsor to view all of their trials.